LNSR
LENSAR, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
LENSAR (LNSR) Stock: Buy, Sell, or Hold?
$4.58
-0.04 (-0.87%)
▼
5d:
-21.58%
30d:
-26.95%
90d:
-44.62%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (62%)
Quality Score
39/100
Position
OVERSOLD
30-Day Fair Range
$5.40 – $6.37
Position: OVERSOLD
Forward P/E & Valuation
-9.0x
CHEAP
vs 14.6x historical avg
Wall Street Target
$11.33
+147.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.30 / $6.05
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: LNSR is down 21.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When LNSR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LNSR is currently trading at $4.58, which is considered oversold relative to its 30-day fair value range of $5.40 to $6.37. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.0) compared to its historical average (14.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, LNSR is showing sideways momentum. Immediate support is located at $4.30, while resistance sits at $6.05.
Market Sentiment: LNSR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.33 (+147.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LNSR is showing sideways momentum. Immediate support is located at $4.30, while resistance sits at $6.05.
Market Sentiment: LNSR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.33 (+147.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.40 -
$6.37
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
61.9%
Trading Range & Key Levels
30-Day Trading Range
$5.40 -
$6.37
Current vs Trading Range
OVERSOLD
Support Level
$4.30
Resistance Level
$6.05
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 147.5% below Wall St target ($11.33)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-8.98
Wall Street Target
$11.33
(+147.5%)
Revenue Growth (YoY)
18.4%
Profit Margin
57.6%
PE vs Historical
-9.0 vs 14.6
CHEAP
Share LNSR Analysis
Share this live LNSR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LNSR)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Aug 13, 2026
Daily AI digest
AI Retail Discussion Summary:
LENSAR reported strong Q2 2026 results with revenue growth of 18%, 20% increase in recurring revenue, and 13% growth in procedures. The company's ALLY robotic laser cataract system continues to gain market traction, with a focus on expanding adoption and increasing utilization.
Key Retail Themes:
Revenue growth
Recurring revenue increase
ALLY system adoption
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:29 AM ET
Data refreshes hourly during market hours. Next update: 3:29 AM
Data refreshes hourly during market hours. Next update: 3:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNSR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 52 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 38 SELL |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 39 SELL |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 45 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LNSR Research Pages
